Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Antiviral activity and safety of the hepatitis B core inhibitor ABI-H0731 administered with a nucleos(t)ide reverse transcriptase inhibitor in patients with HBeAg-negative chronic hepatitis B infection
Antiviral activity and safety of the hepatitis B core inhibitor ABI-H0731 administered with a nucleos(t)ide reverse transcriptase inhibitor in patients with HBeAg-negative chronic hepatitis B infection Fung, S., Sulkowski, M., Lalezari, J., Schiff, E. R., Dieterich, D., Hassanein, T., Kwo, P., Elkhashab, M., Nahass, R., Ayoub, W., Han, S., Bonacini, M., Alves, K., Zayed, H., Huang, Q., Colonno, R., Knox, S., Ramji, A., Bennett, M., Gane, E., Ravendhran, N., Park, J., Jacobson, I., Bae, H., Chan, S., Hann, H., Ma, X., Nguyen, T., Yuen, M. ELSEVIER. 2020: S51-S52View details for Web of Science ID 000786587000087